Connect with us

Technology

Artificial Intelligence in Healthcare Market to Hit US$ 164.16 Billion by 2030 with 49.1% CAGR | MarketsandMarkets™

Published

3 weeks ago

on

DELRAY BEACH, Fla., Dec. 19, 2024 /PRNewswire/ — The global artificial intelligence in healthcare market, valued at US$10.31 billion in 2023, is forecasted to grow at a robust CAGR of 49.1%, reaching US$14.92 billion in 2024 and an impressive US$164.16 billion by 2030. The market growth is primarily driven by the increase in the chronic diseases such as heart disease, stroke, diabetes, and cancer subsequently putting significant pressure on healthcare service providers to optimize their operations. Moreover, technological advancements in machine learning algorithms, cloud computing, data analytics, and other sophisticated technologies is largely driving the market growth. Companies are updating their product portfolio to incorporate artificial intelligence into their offerings. For instance, GE Healthcare, Cognizant, and many more have upgraded their Artificial Intelligence (AI) in healthcare capabilities to enhance overall healthcare experience. However, the resistance among medical practitioners to adopt AI-based solutions, and high implementation costs are expected to restrain the market growth to a certain extent.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=54679303

Browse in-depth TOC on “Artificial Intelligence in Healthcare Market”
455 – Tables
54 – Figures
386 – Pages

The global Artificial Intelligence (AI) in healthcare market is segmented into integrated solutions, niche/point solutions, AI technology, and services, by offering. The integrated solutions segment is accounted for the largest share in 2023. The large share of this segment is attributed to the increasing demand for seamless software-service combinations that address complex healthcare challenges like workflow optimization, predictive analytics, and personalized care. These providers enable healthcare organizations to adopt AI solutions more effectively by offering end-to-end support, from implementation to ongoing system management, which reduces operational complexity and ensures regulatory compliance. Additionally, advancements in AI-powered platforms such as clinical decision support, coupled with rising investments in healthcare IT infrastructure, fuel this trend by making integrated solutions more attractive to hospitals and clinics seeking value-based care models.

Based on tools, the AI in healthcare market is segmented into machine learning, natural language processing, generative AI, computer vision, image analysis, and other tools. In 2023, the machine learning segment accounted for the largest share of the market. The large share of this segment can be attributed to the enormous availability of data, also called big data, and the increasing adoption of ML by hospitals, research centers, and other healthcare institutions to improve patient health. ML is being implemented in healthcare to deal with large volumes of data, streamline hospital administrative processes, map and treat infectious diseases, and personalize medical treatments. These advantages are poised to increase the adoption of ML in the healthcare industry.

The Artificial Intelligence (AI) in healthcare market is divided into clinical applications and non-clinical applications, by application. In 2023, the clinical applications segment is expected to demonstrate highest growth rate during the forecast period. The high adoption of artificial intelligence (AI) in healthcare for clinical applications is driven by its ability to improve diagnostic accuracy, optimize treatment plans, and enhance patient outcomes. AI-powered tools, such as predictive analytics and imaging diagnostics, support clinicians in early disease detection and personalized care, addressing growing demands for efficiency and precision in healthcare delivery. Additionally, advancements in machine learning and natural language processing enable integration into clinical workflows, while rising investments and favourable regulatory policies further accelerate adoption.

The AI in healthcare market is studied for the five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The North American region dominated the market due to the high per capita healthcare expenditure, ongoing technological developments, particularly in machine learning & deep learning, the rising demand for precision medicine, and the favourable reimbursement scenario. The surging number of patients with chronic disorders and significant investments by government & private entities toward healthcare information technology further propel the growth. Moreover, the competitive scenario in North America motivates key market players to develop innovative tools, driving continuous growth in service offerings.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=54679303

The prominent players operating in the Artificial Intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Veradigm LLC (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), Amazon Web Services, Inc. (US), SOPHiA GENETICS (US), Riverian Technologies (US), Terarecon (ConcertAI) (US), 3M (US), Tempus (US), Viz.ai (US). These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers and acquisitions to strengthen their market presence in the Artificial Intelligence (AI) in healthcare market.

Koninklijke Philips N.V. (Netherlands) is one of the key players that offers Artificial Intelligence (AI) in healthcare solutions. Philips leverages AI in healthcare to deliver innovative solutions across diagnostic imaging, patient monitoring, and precision medicine. Its advanced AI-driven platforms, such as the Philips HealthSuite, enable the integration and analysis of vast clinical data, supporting personalized treatment plans and improved patient outcomes. AI capabilities are embedded in imaging tools enhances diagnostic accuracy and streamlines radiology workflows. The company’s solutions focus on operational efficiencies, including workflow automation and predictive analytics, empowering healthcare providers to deliver value-based care. Philips’ strong emphasis on collaboration with hospitals and technology partners further accelerates the adoption of AI in healthcare. Philips has a significant global presence, serving over 100 countries across North America, Europe, Asia-Pacific, Latin America, and Africa. Its operations are supported by a strong network of subsidiaries, including Philips Healthcare, Philips Medical Systems, and Philips Research. The company maintains strategic R&D centers in key markets and collaborates with leading medical institutions to drive innovation in health technology.

Microsoft (US) is one of the leading providers of software & tools that leverages advanced AI capabilities in healthcare to enhance patient outcomes, streamline operations, and drive innovation. Its Azure-based AI solutions support diverse applications like medical imaging, genomics, and precision medicine. Microsoft also offers healthcare-specific AI models through its Azure AI Model Catalog, designed to support hospitals and research institutions in building and deploying tailored AI solutions efficiently. Additionally, the integration of Nuance’s AI-powered clinical and diagnostic tools bolsters its capacity to support healthcare providers in decision-making and care delivery. Microsoft has a strong global presence, with key operations supported through its Azure cloud infrastructure across regions like North America, Europe, Asia-Pacific, and the Middle East. Its geographic footprint enables widespread access to advanced AI tools for healthcare providers, ensuring scalability, data security, and compliance with local regulations like GDPR in Europe and HIPAA in the U.S.

For more information, Inquire Now!

Related Reports:

Home Healthcare Market

Healthcare IT Market

Healthcare BPO Market

Artificial Intelligence in Medical Diagnostics Market

Artificial Intelligence in Genomics Market

Get access to the latest updates on Artificial Intelligence (AI) in Healthcare Companies and Artificial Intelligence (AI) in Healthcare Market Size

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

 

View original content:https://www.prnewswire.com/news-releases/artificial-intelligence-in-healthcare-market-to-hit-us-164-16-billion-by-2030-with-49-1-cagr–marketsandmarkets-302335998.html

SOURCE MarketsandMarkets

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Singapore’s Sodion Energy Secures MWh Supply of US Developed Advanced Sodium-Ion Batteries from UNIGRID

Published

29 minutes ago

on

January 12, 2025

By

SINGAPORE, Jan. 13, 2025 /PRNewswire/ — Sodion Energy, a leading provider of sodium-ion batteries for e-mobility and integrated energy storage solutions in Southeast Asia, has secured a landmark agreement for an initial 10 MWh supply of advanced sodium-ion batteries developed by UNIGRID Inc., a California-based innovator in sodium-ion battery technology.

This collaboration strengthens Sodion Energy’s ability to address the region’s rising demand for affordable, eco-friendly, and high-performance battery solutions across mobility and energy storage sectors.

“Our collaboration with UNIGRID is a game-changer,” said Dr. CC Hang, Chairman of Sodion Energy. “These next-generation sodium-ion batteries will allow us to tackle key markets, starting with lead-acid battery replacements in e-mobility and extending into large-scale renewable energy projects and grid stabilization initiatives.”

Sodium-ion batteries offer distinct advantages, including cost-efficiency, enhanced safety, and the use of abundant raw materials, making them a sustainable choice for energy storage. With fast-charging capabilities and intrinsic non-flammability, they are exceptionally suited to Southeast Asia’s tropical climate and rapidly growing energy needs.

With a strategic focus on advanced battery technologies, Sodion Energy is poised to play a key role in driving Southeast Asia’s transition to cleaner, safer, and more sustainable energy solutions.

Website: https://sodione.com

Follow us on LinkedIn: Sodion Energy

About Sodion Energy

Headquartered in Singapore, Sodion Energy is an applications engineering leader driving the commercialization of Sodium-ion batteries across Southeast Asia. SE’s sodium-ion pack solutions are tailored to meet the diverse needs of industries such as mobility and energy storage, contributing to a more sustainable future.

View original content:https://www.prnewswire.com/apac/news-releases/singapores-sodion-energy-secures-mwh-supply-of-us-developed-advanced-sodium-ion-batteries-from-unigrid-302347661.html

SOURCE UNIGRID and Sodion Energy Pte. Ltd

Continue Reading

Technology

AirCheck Australia & New Zealand Renamed as RCS MEDIA MONITORS

Published

1 hour ago

on

January 12, 2025

By

SYDNEY, Jan. 13, 2025 /PRNewswire/ — AirCheck, a leading provider of broadcast monitoring services in Australia and New Zealand is pleased to announce its renaming as RCS MEDIA MONITORS, effective immediately.

AirCheck monitors songs and commercials providing almost real time reporting tools for radio and television broadcasters, music media, record companies, advertising agencies and industry analysts.

This change reflects the company’s growth, expanded service offerings, and a strengthened focus on providing comprehensive media intelligence.

The new name, RCS MEDIA MONITORS, builds on the expertise of its parent company, RCS, to offer enhanced monitoring solutions. By integrating RCS’s global technology and resources, the company will provide clients with a broader range of tools for tracking and analysing media campaigns across a variety of platforms and markets.

“We’re excited to take this step forward,” said Philippe Generali, President and CEO of RCS Global. “The rebranding to RCS MEDIA MONITORS allows us to expand our reach and improve our services, giving clients access to deeper insights and a wider array of media monitoring tools. With RCS’s support, we can offer more robust data and solutions that cover not just broadcast, but also digital and emerging media channels.”

The name change signals the company’s commitment to evolving with the changing media landscape. With RCS MEDIA MONITORS, clients can expect the same reliable monitoring services they’ve trusted for over 20 years in Australia and 15 years in NZ.

www.rcsmediamonitors.com.au

About RCS MEDIA MONITORS

RCS MEDIA MONITORS (formerly AirCheck) is a leading provider of broadcast monitoring and media intelligence solutions in Australia, New Zealand and India. The company helps clients across industries optimise media strategies, measure performance, and gain insights from a wide range of traditional and digital media. RCS MEDIA MONITORS is part of RCS, a global leader in broadcast automation and media technology.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/aircheck-australia–new-zealand-renamed-as-rcs-media-monitors-302347810.html

SOURCE RCS MEDIA MONITORS

Continue Reading

Technology

iM Global Partner mourns the passing of Philippe Uzan

Published

1 hour ago

on

January 12, 2025

By

PARIS, Jan. 13, 2025 /PRNewswire/ — It is with deep sadness that iM Global Partner (iMGP) announces the passing, one month ago, of our dear friend and colleague, Philippe Uzan.

 

 

Philippe’s exceptional career in asset management spanned more than 30 years and is marked by remarkable achievements in the organizations for which he worked and deep contributions to the industry as a whole. His passing is a tremendous loss to all who knew and worked with him.

Philippe joined iM Global Partner in February 2020 as Deputy CEO and CIO Global Asset Management, responsible for overseeing our financial strategies and products and designing value-added investment solutions for our clients across Europe and the United States.

His expertise spanned all asset classes, and he had a deep understanding of markets and their impact on investors and their investment needs. He was an eloquent man who contributed a number of papers and articles to the media, always with the intention of educating and making financial concepts more relatable. He has left an indelible mark on our organization and on the broader industry.

Prior to joining iM Global Partner, Philippe was latterly Chief Investment Officer at Edmond De Rothschild Asset Management, where he worked for 11 years and where he led the portfolio management teams, optimizing the synergies between analysis and portfolio management. He previously spent three years as Research and Global Asset Allocation Director, where he developed the portfolio management and research teams and modernized investment processes and the product range.

Philippe began his career as an Equity Derivatives Trader at Société Générale and held roles at AGF Asset Management (now part of Allianz Global Investors) and Natixis AM.

Throughout his career, Philippe’s outstanding intelligence, humility, and collaborative spirit earned him the respect and admiration of his peers.

Philippe Couvrecelle, Founder and CEO of iM Global Partner, expressed his heartfelt condolences: “It was with infinite sadness and pain that I learned of Philippe’s passing from a devastating illness. I had known Philippe closely for almost 20 years, as we worked together for Natixis, Edmond de Rothschild and iMGP. I pay immense tribute to his humanity, his sense of humor, his brilliant intelligence and his presence, which I will deeply miss. We had shared so much and still had so much to do together. In his memory, we will continue our path forward with strength, success and intensity, always preserving our values and our company culture to which he was so attached.

We will all miss Philippe enormously at iM Global Partner. He will be remembered not only for his professional achievements but also for his warmth, generosity, kindness and his unwavering dedication to his colleagues and community. Our thoughts are with his wife and three children, his family, friends and loved ones during this difficult time.”

CONTACT: media@imgp.com

 

 

SOURCE iM Global Partner

Continue Reading

Trending